← Leaderboards
Martin McMahon
Utah State Higher Education System--University Of Utah
$9,931,696
Attributed
$9,931,696
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,931,696 · 6
By mechanism
R01$8,869,669 · 3
P30$1,062,027 · 3
Top collaborators
No co-investigators on record.
Most similar at Utah State Higher Education System--University Of Utah
Same institution · by research overlap
- David W Wetter$26,188,223
- Kolawole S Okuyemi$22,062,313
- Sheri L. Holmen$10,554,952
- Guilherme Del Fiol$10,160,709
- Tracy Onega$9,327,018
Others in their field
Top investigators on “Scientist”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- David Heimbrook · Leidos Biomedical Research, Inc.$322,837,216
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ScientistDesignGeneticMalignant NeoplasmsResourcesCancer TherapyPathway InteractionsBaseProgramsEvaluationTargeted TreatmentPublishingPre-ClinicalCancer CellSignal TransductionResponseOncogenesSignal PathwayCancer PatientPhysiciansDrug ResistanceOncogenicMissionBiochemistry
Grant awards (54)
Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy$385,000
R01 · FY2025 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$385,000
R01 · FY2025 · CA · contact PI
Experimental Therapeutics (ET)$275,704
P30 · FY2025 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$13,644
R01 · FY2025 · CA · contact PI
Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy$385,000
R01 · FY2024 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$365,750
R01 · FY2024 · CA · contact PI
Experimental Therapeutics (ET)$51,906
P30 · FY2024 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$23,236
R01 · FY2024 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$384,375
R01 · FY2023 · CA · contact PI
Experimental Therapeutics (ET)$65,936
P30 · FY2023 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$11,267
R01 · FY2023 · CA · contact PI
Experimental Therapeutics (ET)$73,159
P30 · FY2022 · CA · contact PI
Experimental Therapeutics (ET)$60,379
P30 · FY2021 · CA · contact PI
Experimental Therapeutics (ET)$60,379
P30 · FY2020 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$319,893
R01 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$60,476
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$14,284
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$11,113
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$8,213
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$8,169
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$5,972
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$4,268
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$3,813
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$3,571
P30 · FY2019 · CA · contact PI
Experimental Therapeutics Program (Project-003)$3,453
P30 · FY2019 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$329,788
R01 · FY2018 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$249,999
R01 · FY2018 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$50,760
R01 · FY2018 · CA · contact PI
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy$344,200
R01 · FY2017 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$329,788
R01 · FY2017 · CA · contact PI
Identifying the molecular mechanisms of the regulation of integrin B3 expression by the MAP Kinase pathway$50,494
R01 · FY2017 · CA · contact PI
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy$333,467
R01 · FY2016 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$329,788
R01 · FY2016 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$329,788
R01 · FY2015 · CA · contact PI
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy$228,008
R01 · FY2015 · CA · contact PI
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy$137,849
R01 · FY2015 · CA · contact PI
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy$353,482
R01 · FY2014 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$31,600
R01 · FY2014 · CA · contact PI
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy$362,392
R01 · FY2013 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$316,587
R01 · FY2013 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$338,369
R01 · FY2012 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$339,987
R01 · FY2011 · CA · contact PI
PANCREAS CANCER PROGRAM$69,688
P30 · FY2011 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$352,223
R01 · FY2010 · CA · contact PI
PANCREAS CANCER PROGRAM$70,562
P30 · FY2010 · CA · contact PI
Studying the initiation, progression and therapy of lung cancer in mouse models$345,416
R01 · FY2009 · CA · contact PI
Regulation of apoptosis by mutationally activated B-Raf$283,708
R01 · FY2009 · CA · contact PI
PANCREAS CANCER PROGRAM$71,725
P30 · FY2009 · CA · contact PI
Regulation of apoptosis by mutationally activated B-Raf$283,708
R01 · FY2008 · CA · contact PI
PANCREAS CANCER PROGRAM$74,362
P30 · FY2008 · CA · contact PI
Regulation of apoptosis by mutationally activated B-Raf$283,708
R01 · FY2007 · CA · contact PI
PANCREAS CANCER PROGRAM$64,895
P30 · FY2007 · CA · contact PI
Regulation of apoptosis by mutationally activated B-Raf$292,182
R01 · FY2006 · CA · contact PI
Regulation of apoptosis by mutationally activated B-Raf$299,213
R01 · FY2005 · CA